Pulmonary tuberculosis in patient on intermittent haemodialysis.
作者信息
Ogg C S, Toseland P A, Cameron J S
出版信息
Br Med J. 1968 May 4;2(5600):283-4. doi: 10.1136/bmj.2.5600.283.
Abstract
摘要
相似文献
1
Pulmonary tuberculosis in patient on intermittent haemodialysis.间歇性血液透析患者的肺结核
Br Med J. 1968 May 4;2(5600):283-4. doi: 10.1136/bmj.2.5600.283.
2
3
A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus PAS.对采用异烟肼加链霉素间歇（每周两次）方案或异烟肼加对氨基水杨酸每日方案进行一年化疗后的静止期肺结核患者进行了为期两年的随访。
Tubercle. 1966 Jun;47(2):178-89. doi: 10.1016/s0041-3879(66)80034-x.
4
5
Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.双周注射链霉素与异烟肼联用每日服用对氨基水杨酸与异烟肼治疗肺结核方案的对比研究
J Indian Med Assoc. 1967 Aug 16;49(4):162-5.
6
[Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
Klin Med (Mosk). 1973 Jul;51(7):89-92.
7
Clinical experience of intermittent treatment in the United Kingdom.英国间歇性治疗的临床经验。
Tubercle. 1968 Mar;49:Suppl:83-5. doi: 10.1016/s0041-3879(68)80058-3.
8
9
引用本文的文献
1
Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.成人活动性肺结核的治疗：现行标准和最新进展。传染病药师学会的观点。
Pharmacotherapy. 2009 Dec;29(12):1468-81. doi: 10.1592/phco.29.12.1468.
2
Tuberculosis in patients having dialysis.接受透析治疗患者的结核病
Br Med J. 1980 Jun 21;280(6230):1533. doi: 10.1136/bmj.280.6230.1533-a.
3
Tuberculosis in maintenance haemodialysis patients. Study from an endemic area.维持性血液透析患者的结核病。来自地方性流行地区的研究。
Postgrad Med J. 1981 Aug;57(670):492-8. doi: 10.1136/pgmj.57.670.492.
4
Clinical pharmacokinetics of the antituberculosis drugs.抗结核药物的临床药代动力学。
Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.
5
Antibacterial agents in renal failure.肾衰竭中的抗菌药物
Br Med J. 1971 Mar 20;1(5750):621-2.
6
Treatment of pulmonary tuberculosis in a patient on maintenance haemodialysis.维持性血液透析患者的肺结核治疗
Postgrad Med J. 1974 Jul;50(585):478. doi: 10.1136/pgmj.50.585.478.
7
Clinical pharmacokinetics of isoniazid.异烟肼的临床药代动力学
Clin Pharmacokinet. 1979 Nov-Dec;4(6):401-22. doi: 10.2165/00003088-197904060-00001.
8
Renal failure, drug pharmacokinetics and drug action.肾衰竭、药物药代动力学与药物作用
Clin Pharmacokinet. 1976;1(2):99-120. doi: 10.2165/00003088-197601020-00002.
本文引用的文献
1
Studies on the metabolism of isoniazid. l. Development and application of a fluorometric procedure for measuring isoniazid in blood.异烟肼代谢的研究。一、一种用于测定血液中异烟肼的荧光测定法的开发与应用。
Am Rev Respir Dis. 1960 Apr;81:485-97. doi: 10.1164/arrd.1960.81.4.485.
2
PAS SERUM CONCENTRATIONS OBTAINED WITH AN ADEGRATE GRANULE PREPARATION OF PAS AND ISONIAZID.使用对氨基水杨酸（PAS）和异烟肼的合适颗粒制剂所获得的血清PAS浓度。
Tubercle. 1964 Sep;45:276-8. doi: 10.1016/s0041-3879(64)80020-9.
3
Estimation of isoniazid.异烟肼的测定
Lancet. 1954 Mar 27;266(6813):656-7. doi: 10.1016/s0140-6736(54)92355-7.
4
A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels.肾病患者抗生素使用指南。推荐剂量及影响血清水平因素表。
Ann Intern Med. 1967 Jul;67(1):151-8. doi: 10.7326/0003-4819-67-1-151.
Zotero 插件